<SEC-DOCUMENT>0001415889-25-006494-index.html : 20250304
<SEC-HEADER>0001415889-25-006494.hdr.sgml : 20250304
<ACCEPTANCE-DATETIME>20250304161522
ACCESSION NUMBER:		0001415889-25-006494
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250301
FILED AS OF DATE:		20250304
DATE AS OF CHANGE:		20250304

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Balthaser Kevin
		CENTRAL INDEX KEY:			0001957554
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37581
		FILM NUMBER:		25704601

	MAIL ADDRESS:	
		STREET 1:		C/O ACLARIS THERAPEUTICS, INC.
		STREET 2:		701 LEE ROAD, SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		701 LEE ROAD
		STREET 2:		SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		484-324-7933

	MAIL ADDRESS:	
		STREET 1:		701 LEE ROAD
		STREET 2:		SUITE 103
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-03042025_040308.xml
<TEXT>
Document 1 - file: form4-03042025_040308.html

Document 1 - RAW XML: form4-03042025_040308.xml

</DOCUMENT>
</SEC-DOCUMENT>